Results 121 to 130 of about 5,637 (158)

Evolutionary and Modification Features of Two Monkeypox Virus Strains: Insights from Integrated Genomic and Epigenomic Analyses. [PDF]

Viruses
Zhao Z, Zhang B, Han J, Lin D, Liu Y, Jia L, Li H, Li J, Wang X, Wen H, Li L.   +10 more
europepmc   +1 more source

Suppressor of cytokine signaling (SOCS) proteins in human retroviral infections. [PDF]

Mol Biol Rep
Farjami Z, Akbarin MM, Álvarez HR.
europepmc   +1 more source

Deaminase Modulation Driving a New Era in Drug Development. [PDF]

Int J Mol Sci
Lindley RA.
europepmc   +1 more source

<i>CDK4/6</i> Inhibitors in Breast Cancer: Clinical Applications, Translational Insights, and Future Directions. [PDF]

Cancers (Basel)
Guan M, Hao H.
europepmc   +1 more source

Hereditary breast cancer: emerging roles of non-coding RNAs. [PDF]

Hereditas
Yang Z, Guha D, Zhang L, Diao H, Bagchi A.   +4 more
europepmc   +1 more source

How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy? [PDF]

J Antimicrob Chemother
Gilbert M, Ferré VM, Guilbaud R, Digumber M, Peytavin G, Damond F, Le Hingrat Q, Yazdanpanah Y, Descamps D, Charpentier C, Joly V, Ghosn J.   +11 more
europepmc   +1 more source

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer. [PDF]

Nat Genet
Gupta A, Gazzo A, Selenica P, Safonov A, Pareja F, da Silva EM, Brown DN, Shao H, Zhu Y, Patel J, Blanco-Heredia J, Stefanovska B, Carpenter MA, Chen Y, Vegas I, Pei X, Frosina D, Jungbluth AA, Ladanyi M, Curigliano G, Weigelt B, Riaz N, Powell SN, Razavi P, Harris RS, Reis-Filho JS, Marra A, Chandarlapaty S.   +27 more
europepmc   +1 more source

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. [PDF]

Clin Infect Dis
Wensing AM, Charpentier C, Calvez V, Ceccherini-Silberstein F, Günthard HF, Jacobsen DM, Paredes R, Shafer RW, Richman DD.   +8 more
europepmc   +1 more source

Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets. [PDF]

Signal Transduct Target Ther
Zhang KY, Zhu XZ, Yan YX, Ying XH, Zhang J, Wang ZH.   +5 more
europepmc   +1 more source

Effects of thymidylate synthase inhibitors differ in genomic uracilation and mutagenic potential. [PDF]

Life Sci Alliance
Holub E, Papp G, Pálinkás HL, Szajkó MB, Izrael R, Róna G, Vértessy BG, Békési A.   +7 more
europepmc   +1 more source